Results 191 to 200 of about 7,284,024 (312)

Improving the care of people affected by post-COVID syndrome (LCovB):study protocol of a mixed-methods study. [PDF]

PLoS One
Burchardi JM, Brünger M, Freitag H, Brock A, Scheibenbogen C, Kohzer N, Kexel E, Kohl R, Rückgauer L, Schmitz E, Budnick A, Schuster J.   +11 more
europepmc   +1 more source

Nonmelanoma Skin Cancer Risk With JAK Inhibitors Compared to Interleukin‐6 Receptor Inhibitors in Rheumatoid Arthritis: Results From a National Cohort Study

Arthritis &Rheumatology, EarlyView.
Objective Nonmelanoma skin cancer (NMSC) is one of the most common malignancies in rheumatoid arthritis (RA). This analysis assessed NMSC risk with JAK inhibitors (JAKi) compared to interleukin‐6 receptor inhibitors (IL‐6Ri). Methods This study used data from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis linked to the
Zixing Tian, Lianne Kearsley‐Fleet, Sizheng Steven Zhao, James Galloway, Mark Lunt, Kath Watson, Narges Azadbakht, British Society for Rheumatology Biologics Register in Rheumatoid Arthritis Contributors Group, Kimme L. Hyrich   +8 more
wiley   +1 more source

A 12-Month Trial-Based Economic Evaluation Comparing Positive Parenting Program (Triple P) and Circle of Security Parenting Program (COSP) Versus Treatment as Usual for Families With Young Children (2-6 Years). [PDF]

J Eval Clin Pract
Tarride JE, Blackhouse G, Harvey-Younis N, Rieder AD, Melendez-Torres GJ, Joshi D, Demy J, MacMillan H, Attard C, Jack SM, Atkinson L, Kimber M, Bennett T, Gonzalez A.   +13 more
europepmc   +1 more source

Metropolitan Life Insurance Company

Felicitación de Navidad (en prensa) de la Metropolitan Life Insurance Company.Repository/Location: Museo del ...
Metropolitan Life Insurance Company
core  

Deucravacitinib in Active Psoriatic Arthritis: Efficacy and Safety up to 52 Weeks From the Randomized, Double‐Blind, Phase 3 POETYK PsA‐2 Trial

Arthritis &Rheumatology, Accepted Article.
Objective To assess the efficacy and safety of deucravacitinib, an oral, selective tyrosine kinase 2 inhibitor, in patients with psoriatic arthritis (PsA) who were naive to biologic disease‐modifying antirheumatic drugs or received tumor necrosis factor inhibitors. Methods In the 52‐week (W), double‐blind, placebo‐controlled, phase 3 POETYK PsA‐2 study
Philip J. Mease, Vinod Chandran, April W. Armstrong, Ricardo Blanco, Alexis Ogdie, Evan L. Siegel, Alice B. Gottlieb, Xiaofeng Zeng, Diamant Thaçi, Mitsumasa Kishimoto, Hendrik Schulze‐Koops, Alan Kivitz, Eva Dokoupilová, Akimichi Morita, Eric M. Ruderman, Michael Plewinski, Kejia Wang, Caroline Sardinas, Eleni Vritzali, John Vaile, Atul Deodhar   +20 more
wiley   +1 more source

Alzheimer's disease burden in China (ABC) study: protocol for a nationwide multicentre cross-sectional and prospective cohort study. [PDF]

BMJ Open
Wang Y, Qin Q, Yang K, Yu M, Yao Y, Gong C, Guo J, Yang L, Tang Y.   +8 more
europepmc   +1 more source

Risk of Cancer According to Duration of Targeted Therapy Exposure in Spondyloarthritis: A Nationwide Cohort Study From the French Health Insurance Database

Arthritis &Rheumatology, EarlyView.
Objective To assess the association between duration of targeted therapy exposure and cancer risk in patients with spondyloarthritis (SpA), including those with psoriatic arthritis, axial SpA, and other subtypes. Methods This nationwide cohort study used the French health insurance database to identify adults with SpA initiating a targeted therapy ...
Karine Tankovic, Pascal Claudepierre, Tat Thang Vo, Tran Trong Khoi Le, Siham Iggui, Laetitia Penso, Emilie Sbidian, Laura Pina Vegas   +7 more
wiley   +1 more source

Factors Influencing Medication Literacy in Young and Middle-Aged Patients with NYHA Class I-III Heart Failure After Percutaneous Coronary Intervention: A Qualitative Study. [PDF]

Patient Prefer Adherence
Li JY, Ren ZQ, Wang XC, Jiang WJ, Ding L, Li C, Huang PY, Wang LC, Chen L.   +8 more
europepmc   +1 more source

Incidence and disease course of polymyalgia rheumatica during two decades: a nationwide study across healthcare sectors in Denmark

Arthritis &Rheumatology, Accepted Article.
Objective A new algorithm enables the identification of patients with polymyalgia rheumatica (PMR) across healthcare sectors in Denmark. We estimated annual incidence rates from 2003 to 2024 and described the disease course, including the occurrence of late‐onset GCA and prednisolone (PDN) treatment. Methods A Danish nationwide, population‐based cohort
Agnete O Donskov, Ellen M Hauge, Annette De Thurah, Mette Nørgaard, Kresten K Keller   +4 more
wiley   +1 more source

The Impact of Pediatric Dermatologic Conditions on Mental Health in Underserved Communities in the United States: Barriers and Strategies for Their Mitigation. [PDF]

Cureus
Pedreira C, Mayrovitz HN.
europepmc   +1 more source